Our Custom Problem-Solving Gets Your Therapies to Market Faster. Clinical development problems delay product marketing approval. When you hire HBP, our strategies and tactics remove obstacles to get your product to patients faster.
A Phase 3 clinical trial stage Boston biotech needed their first product on the market. They hired HBP on their small team to rapidly get their data into a clear, compelling, compliant submission. Our biotech client got their first product, an oncology therapy, approved 3 months earlier than expected, generating $6.4 million in revenue and shifting a Wall Street analyst rating to Buy because we were a key member on the NDA submission team.
An Australian clinical stage biotech needed to start their Phase 1/2 trial. They hired HBP. Our biotech client enrolled and conducted their early-stage clinical trial for an oncology product because we developed their clinical trial monitor training, protocol and other clinical trial initiation documents based on our deep knowledge from >1,000 clinical trial documents developed at global biopharma firms.
A Venture Capital wanted to understand the digital health market before investing. They came to HBP to rapidly understand if this space was investible for them.
A global pharma firm needed to get a new product on the market. They hired HBP. Our client launched a new metastatic breast cancer therapy, a key part of their 5-year plan in record time, facilitated by us increasing agility by restructuring their R&D processes, helping teams and functions be tightly aligned and making SOPs lean and clear, cutting excess red tape processes in half, so staff could focus effectively on the therapy approval and launch.
A global biopharma needed to integrate R&D processes across global cultures and functions. They hired HBP to streamline R&D operations like Pharmacovigilance, Medical Affairs, Regulatory and more. HBP got functions working smoothly across countries & regions. We cut many processes by 50%.
Global Pharma Firm needed to quickly respond to a new FDA regulation that affected nearly every product in their portfolio. They hired HBP. Our client met their company-wide clinical trial transparency requirement with delivery of ~700 regulatory documents, on time and on budget, without taking staff away from development and launch of new therapies.
Healing people together, year after year.
©Copyright 2005 – 2024 | Hughes BioPharma Advisors | All Rights Reserved
